Protagonist Therapeutics, Inc. Common Stock (PTGX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Stock analysis for Protagonist Therapeutics Inc (PTGX:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Find real-time PTGX - Protagonist Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. PTGX stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Ikarian Capital LLC, Jacobs Levy Equity Management Inc., Renaissance Technologies LLC, Prudential Financial Inc., Nuveen Asset Management LLC, Spark Investment Management LLC, and State Street Corp. Company insiders that have bought Protagonist Therapeutics stock in the last two years include Bryan Giraudo, Donald A Kalkofen, Harold E Selick, and Suneel Gupta. Real-time trade and investing ideas on Protagonist Therapeutics PTGX from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal.

Stock quote for Protagonist Therapeutics, Inc. Common Stock Common Stock (PTGX) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq.

PTGX | Complete Protagonist Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Protagonist Therapeutics. PTGX 6.82 1.08 (13.67%). NASDAQUpdated Mar 16, 2020 8:34 PM. 1,397. Watchers. Watch. Filter by: Real-Time. 0 New Post.

Common Stock Shares Outstanding, 27,206,447 shares (as of 2019-09-30) Protagonist Therapeutics, Inc. (NASDAQ:PTGX) has 86 institutional investors and  

Find the latest Protagonist Therapeutics, Inc. (PTGX) stock quote, history, news and other vital information to help you with your stock trading and investing. PTGX | Complete Protagonist Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Get breaking news and analysis on Protagonist Therapeutics, Inc. (PTGX) stock, price quote and chart, trading and investing tools. View Protagonist Therapeutics, Inc. PTGX investment & stock information. Get the latest Protagonist Therapeutics, Inc. PTGX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Stock quote for Protagonist Therapeutics, Inc. Common Stock Common Stock (PTGX) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq.

investment & stock information. Get the latest Protagonist Therapeutics, Inc. PTGX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Common Stock Shares Outstanding, 27,206,447 shares (as of 2019-09-30) Protagonist Therapeutics, Inc. (NASDAQ:PTGX) has 86 institutional investors and   View the latest PTGX stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of PROTAGONIST THERAPEUTICS, INC.. Based on 1 Wall Street analysts offering stock ratings for Protagonist Therapeutics in the last 3 months (by analysts ranked 0 to 5 stars). All Analysts. Get today's Protagonist Therapeutics Inc stock price and latest PTGX news as well as Protagonist Therapeutics real-time stock quotes, technical analysis, full  Current Technical Analysis and interactive chart for $PTGX stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals. Company Name: Protagonist Therapeutics Inc, Stock Symbol: PTGX, Industry: Biotechs, Total Posts: 27, Last Post: 12/5/2019 11:26:00 AM.

Real-time trade and investing ideas on Protagonist Therapeutics PTGX from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal.

investment & stock information. Get the latest Protagonist Therapeutics, Inc. PTGX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Common Stock Shares Outstanding, 27,206,447 shares (as of 2019-09-30) Protagonist Therapeutics, Inc. (NASDAQ:PTGX) has 86 institutional investors and  

• how to purchase online gift cards
• requirements trade steam
• rand dollar graph 50 years
• oil and gas leveraged etf
• how to calculate market capitalization weighted index
• what are the blue chip stocks in usa
• eurostock 50 historico
• ehhefpr
• ehhefpr
• ehhefpr